first glp 1 drug Glucagon-like peptide-1 List of GLP-1 Receptor Agonists

Acknowledgment: We acknowledge and appreciate our patient for providing permission to publish this case report

After discontinuing its internal GLP-1 in May of 2025 for causing liver issues, Pfizer won a bidding war against seven other companies for Metsera, which is developing a variety of incretin assets, paying $10 billion in one of 2025s largest M&A deals

Arch Gynecol Obstet

A common refrain in survey and qualitative data is some variation of "I just stopped thinking about food all day." That phenomenon often called food noise reduction is one of the most consistent subjective effects of the class

Ultimately, tailored adjustments help you overcome the potential risks and barriers that might otherwise cause you to stop your medication